 |
|
|
| |
On-Treatment HCV RNA as a Predictor of SVR12 in Patients With Genotype 1-6 HCV Infection Treated With Sofosbuvir/Velpatasvir for 12 Weeks: An Analysis of the ASTRAL-1, ASTRAL-2, and ASTRAL-3 Studies
|
| |
| |
Reported by Jules Levin
EASL 2016 Barcelona
Saleh Alqahtani,1 Stefan Zeuzem,2 Stefan Bourgeois,3 Phillippe Mathurin,4 Sergio Rojter,5 Gregory Everson,6 Armand Abergel,7 Victor De Ledinghen,8
Lin Liu,9 Xiao Ding,9 John McNally,9 Anu Osinusi,9 Diana M. Brainard,9 G. Mani Subramanian,9 Alessandra Mangia,10 Mark Sulkowski1
1Johns Hopkins University, Baltimore, Maryland, USA; 2Universitatsklinikum Frankfurt, Germany; 3Ziekenhuis Netwerk Antwerpen Stuivenberg, Antwerpen, Belgium; 4Centre Hospitalier Regional Universitaire de Lille, Universite Lille Nord de France; 5National Research Institute, Los Angeles, California, USA;
6University of Colorado School of Medicine, Aurora, USA; 7Universite d'Auvergne, Clermont-Ferrand, France; 8Centre Hospitalier Universitaire de Bordeaux, Pessac, France; 9Gilead Sciences, Inc., Foster City, California; 10Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy
|
| |
|
|
|
|
|
